Search Result "ApoER2"
Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo
Journal: Current Alzheimer Research
Volume: 11 Issue: 6 Year: 2014 Page: 549-557
Author(s): Moran Gilat-Frenkel, Anat Boehm-Cagan, Ori Liraz, Xunde Xian, Joachim Herz, Daniel M. Michaelson
Lipoprotein Receptors in Alzheimer´s Disease: Beyond Lipoprotein Transport
Ebook: Advances in Alzheimer's Research
Volume: 1 Year: 2013
Author(s): Wladislaw Maier,Sebastian Jaeger,Claus U. Pietrzik
Doi: 10.2174/9781608054954113010012
A Comprehensive Review on PCSK9 as Mechanistic Target Approach inCancer Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 1 Year: 2023 Page: 24-32
Author(s): Amita Singh,Pranesh Kumar,Archana Bharti Sonkar,Anurag Kumar Gautam,Abhishek Verma,Biswanath Maity,Himani Tiwari,Nanda Gopal Sahoo,Amit K. Keshari,S.K. Yadav,Sudipta Saha
Functional Role of Lipoprotein Receptors in Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 5 Issue: 1 Year: 2008 Page: 15-25
Author(s): Claus U. Pietrzik, Sebastian Jaeger
Current Progress of Reelin in Development, Inflammation and Tissue Remodeling: From Nervous to Visual Systems
Journal: Current Molecular Medicine
Volume: 16 Issue: 7 Year: 2016 Page: 620-630
Author(s): A. Micera,B. O. Balzamino,F. Biamonte,G. Esposito,R. Marino,F. Fanelli,F. Keller
An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo
Journal: Current Alzheimer Research
Volume: 13 Issue: 8 Year: 2016 Page: 918-929
Author(s): Ishai Luz, Ori Liraz, Daniel M. Michaelson
The LDL-Receptor and its Molecular Properties: From Theory to Novel Biochemical and Pharmacological Approaches in Reducing LDL-cholesterol
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 2 Year: 2020 Page: 317-333
Author(s): Dimitrios Petroglou,Ilias Kanellos,Christos Savopoulos,Georgia Kaiafa,Anastasios Chrysochoou,Panagiotis Skantzis,Stylianos Daios,Apostolos I. Hatzitolios,Georgios Giannoglou
The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimerâs Disease
Journal: Current Drug Discovery Technologies
Volume: 11 Issue: 4 Year: 2014 Page: 243-258
Author(s): Hisashi Nagase,Kohzo Nakayama
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3161-3172
Author(s): Nabil G. Seidah
The Role of MAPK's Signaling in Mediating ApoE4-Driven Pathology In Vivo
Journal: Current Alzheimer Research
Volume: 16 Issue: 4 Year: 2019 Page: 281-292
Author(s): Shiran Salomon-Zimri,Amit Koren,Ariel Angel,Tali Ben-Zur,Daniel Offen,Daniel M. Michaelson